- 全部删除
您的购物车当前为空
AZD-5991是一种抗肿瘤化合物,是高选择性、高效和直接的MCL-1抑制剂,通过激活 Bak 依赖性线粒体凋亡途径诱导癌细胞快速凋亡,可用于多发性骨髓瘤、急性髓性白血病和三阴性炎性乳腺癌。

AZD-5991是一种抗肿瘤化合物,是高选择性、高效和直接的MCL-1抑制剂,通过激活 Bak 依赖性线粒体凋亡途径诱导癌细胞快速凋亡,可用于多发性骨髓瘤、急性髓性白血病和三阴性炎性乳腺癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 993 | In stock | |
| 5 mg | ¥ 2,480 | In stock | |
| 10 mg | ¥ 3,980 | In stock | |
| 25 mg | ¥ 6,270 | In stock | |
| 50 mg | ¥ 8,460 | In stock | |
| 100 mg | ¥ 11,300 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,680 | In stock |
AZD-5991 相关产品
| 产品描述 | AZD-5991, an antitumor compound, is a highly selective, potent and direct MCL-1 inhibitor that induces rapid apoptosis in cancer cells by activating the Bak-dependent mitochondrial apoptotic pathway, used for multiple myeloma, acute myeloid leukemia, and triple-negative inflammatory breast cancer. |
| 靶点活性 | McL1:0.17 nM (Kd), McL1:0.7 nM |
| 体外活性 | 方法:AZD-5991(10-1000nM,24小时)处理一组 MCL 细胞系,使用 CellTiter-Glo 细胞活力测定 (Promega) 进行细胞活力测定。 |
| 体内活性 | 方法:AZD-5991(10-100mg/kg,静脉注射)治疗MOLP-8 肿瘤模型小鼠,评估了AZD-5991 对体内 MOLP-8 肿瘤生长的疗效。 |
| 别名 | AZD5991 |
| 分子量 | 672.26 |
| 分子式 | C35H34ClN5O3S2 |
| CAS No. | 2143061-81-6 |
| Smiles | Cc1c-2c(CSCc3cc(CSc4cc(OCCCc5c(C(O)=O)n(C)c6c-2c(Cl)ccc56)c2ccccc2c4)n(C)n3)nn1C |
| 密度 | 1.42 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: <0.1 mg/mL (insoluble) DMSO: 200 mg/mL (297.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容